Robert I. Blum - Jan 17, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
President & CEO, Director
Signature
/s/ John Faurescu, attorney-in-fact for Mr. Blum
Stock symbol
CYTK
Transactions as of
Jan 17, 2023
Transactions value $
-$327,800
Form type
4
Date filed
1/19/2023, 03:59 PM
Previous filing
Jan 6, 2023
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $96.5K +10K +2.46% $9.65 416K Jan 17, 2023 Direct F1
transaction CYTK Common Stock Sale -$424K -10K -2.4% $42.43 406K Jan 17, 2023 Direct F1
holding CYTK Common Stock 2.08K Jan 17, 2023 by Trust 1 F2
holding CYTK Common Stock 2.08K Jan 17, 2023 by Trust 2 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10K -6.42% $0.00 146K Jan 17, 2023 Common Stock 10K $9.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.
F2 Shares held by The Bridget Blum 2003 Irrevocable Trust.
F3 Shares held by The Brittany Blum 2003 Irrevocable Trust.